Coreage Rx vs MEDVi

Both sell tirzepatide. Coreage Rx costs $199 a month and MEDVi costs $399, a difference of $200 a month or about $2,400 a year. The desk reads it as follows.

Coreage Rx is best overall on true monthly cost. MEDVi is tablet and injection choice. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Coreage Rx advertises $149 and bills $199; MEDVi advertises $399 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.

What each puts on the record: Coreage Rx

• Compounded tirzepatide advertised from $149/month on the annual plan, $199/month otherwise.
• Compounded semaglutide advertised from $99/month on the annual plan.
• A three-month tirzepatide block has been offered at $589 covering any dose up to 15 mg per week.
• Pricing is flat-rate: there is no separate monthly membership stacked on top of the medication price.
• Dose increases within the covered range do not change the price, which is unusual in this market.
• Health coaching is bundled rather than sold as an upgrade.

Where it wins: The advertised price is the billed price — no membership fee arrives in month two. Watch for: The $99 and $149 rates are annual-plan prices. If you want month-to-month, budget $149 and $199 instead, and check the refund terms before prepaying a year.

What each puts on the record: MEDVi

• Compounded tirzepatide injections listed at $399/month.
• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

In each one’s favour

Coreage Rx.

• The advertised price is the billed price — no membership fee arrives in month two.
• Flat pricing across the dose range, so titrating up to 10 mg or 15 mg does not raise the bill.

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

How they score

Coreage Rx scores higher overall at 4.5 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Coreage Rx if cost is the binding constraint. Over a year the gap is about $2,400, which is real money for the same class of medication.
• Pick MEDVi if what it does better matters to you — injection pricing is consistent between the first month and renewals.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Coreage Rx at $199 a month is the more defensible choice on arithmetic alone. MEDVi earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Coreage Rx and MEDVi.

How they sit against everyone else